Sort
326,823 grants matching “clinical trial”
Engineering T cells to Provide Durable Control of HIV-1 Replication
$2,951,367James L Riley · University Of Pennsylvania · U19 · FY2017 · AI
A sequenced-strategy for improving outcomes in patients with knee osteoarthritis pain
$2,951,097Claudia Michelle Campbell · Johns Hopkins University · UH3 · FY2022 · AR
Count Me In: Partnering with patients to define the clinical and genomic landscape of rare aggressive sarcomas in children and adults
$2,950,685Katherine A Janeway · Broad Institute, Inc. · U2C · FY2024 · CA
ECOG-ACRIN Biorepositories to Support NCTN
$2,950,520Ignacio I. Wistuba · Ecog-Acrin Medical Research Foundation · U24 · FY2019 · CA
Increasing the Quality and Efficiency of Clinical Trials (U18)
$2,950,000John H Alexander · Duke University · U18 · FY2022 · FD
Office of Cancer Nanotechnology Research
$2,950,000David Heimbrook · Leidos Biomedical Research, Inc. · N01 · FY2013 · CA
The Immunobiology of Marrow Allografts for Leukemia
$2,949,927Richard J O'Reilly · Sloan-Kettering Inst Can Research · P01 · FY2006 · CA
HPV Vaccine Trial
$2,949,855Allan Hildesheim · Division Of Cancer Epidemiology And Genetics · ZIA · FY2016 · CA
StrokeNet Thrombectomy Endovascular Platform (STEP)
$2,949,824Jordan J. Elm · Medical University Of South Carolina · OT2 · FY2024 · NS
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$2,949,775Ted Ross · University Of Georgia · N01 · FY2024 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$2,949,775Ted Ross · University Of Georgia · N01 · FY2024 · AI
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
$2,949,775Ted Ross · University Of Georgia · N01 · FY2024 · AI
Putting EEG in the Emergency Department
$2,949,240Ahmet Omurtag · Bio-Signal Group Corporation · RC3 · FY2010 · NS
PF614 MPAR Abuse Deterrent opioid prodrug with overdose protection: Pre-Clinical Development and Phase 1 Clinical Trial
$2,949,024Lynn Kirkpatrick · Ensysce Biosciences, Inc. · UG3 · FY2019 · DA
Pre-Clinical and Clinical Evaluation of Skeletal Muscle Activator, CK-2017357 for
$2,948,895Fady Malik · Cytokinetics, Inc. · RC3 · FY2010 · NS
Heartland Cancer Research NCORP
$2,948,688Bryan Faller · Decatur Memorial Hospital · UG1 · FY2017 · CA
Ginkgo Biloba Prevention Trial in Older Individuals
$2,948,467Oscar L. Lopez · University Of Pittsburgh At Pittsburgh · U01 · FY2008 · AT
Immunologic and virologic determinants of congenital Cytomegalovirus transmission and disease in rhesus monkeys
$2,948,233Sallie R. Permar · Weill Medical Coll Of Cornell Univ · P01 · FY2021 · AI
Neurologic Emergencies Treatment Trials Network: Clinical Coordinating Center
$2,948,122William G Barsan · University Of Michigan At Ann Arbor · U01 · FY2011 · NS
SPORE IN BREAST CANCER
$2,948,038University Of Alabama At Birmingham · P50 · FY2002 · CA
REGULATORY MANAGEMENT CENTER (RMC) - Infectious Diseases
$2,947,889Matthew Kirkby · Ppd Development Lp · N01 · FY2025 · AI
Stem Cell Transplantation: Basic/Clinical Research
$2,947,491Rainer F. Storb · Fred Hutchinson Cancer Research Center · P01 · FY2010 · HL
Biomarkers of Cognitive Decline among Normal Individuals: the BIOCARD Cohort
$2,947,254Marilyn S Albert · Johns Hopkins University · U19 · FY2017 · AG
Optimization of HIV vaccines for the induction of cross-reactive antibodies
$2,947,202Shan Lu · Univ Of Massachusetts Med Sch Worcester · U19 · FY2013 · AI
SPORE in Skin Cancer
$2,946,962Brigham And Women'S Hospital · P50 · FY2004 · CA